Selective intracoronary administration of nitroprusside before balloon dilatation prevents slow reflow during percutaneous coronary intervention in patients with acute myocardial infarction

International Heart Journal

Volumn 48, Issue 4, 2007, Pages 423-433

  Shinozaki, Norihiko ^a   Ichinose, Hiroyuki ^a   Yahikozawa, Kumiko ^a   Shimada, Hirohide ^a   Hoshino, Kazuo ^a  

^a Naganoken Koseiren Shinonoi General Hospital   (Japan)

Author keywords

Acute myocardial infarction; Nitroprusside; No reflow; Percutaneous coronary intervention; Primary angioplasty; Slow reflow

Indexed keywords

HYPERTENSIVE FACTOR; NITROPRUSSIDE SODIUM;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY CATHETER; ARTICLE; BALLOON DILATATION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FLUOROSCOPY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HUMAN; HYPOTENSION; INTRACORONARY INFUSION; MAJOR CLINICAL STUDY; MALE; NO REFLOW PHENOMENON; OPERATION DURATION; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SLOW REFLOW PHENOMENON;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BALLOON DILATATION; CATHETERIZATION; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY VESSELS; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; NITROPRUSSIDE; RETROSPECTIVE STUDIES; VASODILATOR AGENTS;

EID: 34648830908     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.48.423     Document Type: Article

References (30)

1. Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1993; 328: 673-9.
2. Zijlstra F, de Boer MJ, Hoorntje JC, Reiffers S, Reiber JH, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993; 328: 680-4.
3. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials. Lancet 2003; 361: 13-20. (Review)
4. Kenner MD, Zajac EJ, Kondos GT, et al. Ability of the no-reflow phenomenon during an acute myocardial infarction to predict left ventricular dysfunction at one-month follow-up. Am J Cardiol 1995; 76: 861-8.
5. Ito H, Maruyama A, Iwakura K, et al. Clinical implication of the "no reflow" phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996; 93: 223-8.
6. Morishima I, Sone T, Okumura K, et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol 2000; 36: 1202-9.
7. Piana RN, Paik GY, Moscucci M, et al. Incidence and treatment of 'no-reflow' after percutanecus coronary intervention. Circulation 1994; 89: 2514-8.
8. Taniyama Y, Ito H, Iwakura K, et al. Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction. J Am Coll Cardiol 1997; 30: 1193-9.
9. Rezkalla SH, Kloner RA. No-reflow phenomenon. Circulation 2002; 105: 656-62. (Review)
10. Myers PR, Barnitt PF, Guerra R Jr, Harrison DG. Characteristics of canine coronary resistance arterioles: importance of endothelium. Am J Physiol 1989; 257: H603-10.
11. Kuo L, Chilian WM, Davis MJ. Interaction of pressure- and flow-induced responses in porcine coronary resistance vessels. Am J Physiol 1991; 261: H1706-15.
12. Bates JN, Baker MT, Guerra R Jr, Harrison DG. Nitric oxide generation from nitroprusside by vascular tissue. Evidence that reduction of the nitroprusside anion and cyanide loss are required. Biochem Pharmacol 1991; 42: S157-65.
13. Hillegass WB, Dean NA, Liao L, Rhinehart RG, Myers PR. Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following percutaneous coronary interventions: initial human clinical experience. J Am Coll Cardiol 2001; 37: 1335-43.
14. Wang HJ, Lo PH, Lin JJ, Lee H, Hung JS. Treatment of slow/no-reflow phenomenon with intracoronary nitroprusside injection in primary coronary intervention for acute myocardial infarction. Catheter Cardiovasc Interv 2004; 63: 171-6.
15. Pasceri V, Pristipino C, Pelliccia F, et al. Effects of the nitric oxide donor nitroprusside on no-reflow phenomenon during coronary interventions for acute myocardial infarction. Am J Cardiol 2005; 95: 1358-61.
16. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med 1985; 312: 932-6.
17. van't Hof AW, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ, Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation 1998; 97: 2302-6.
18. Gibson CM, Cannon CP, Daley WL, et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 1996; 93: 879-88.
19. Kurz MA, Lamping KG, Bates JN, Eastham CL, Marcus ML, Harrison DG. Mechanisms responsible for the heterogeneous coronary microvascular response to nitroglycerin. Circ Res 1991; 68: 847-55.
20. Parham WA, Bouhasin A, Ciaramita JP, Khoukaz S, Herrmann SC, Kem MJ. Coronary hyperemic dose responses of intracoronary sodium nitroprusside. Circulation 2004; 109: 1236-43.
21. Fugit MD, Rubal BJ, Donovan DJ. Effects of intracoronary nicardipine, diltiazem, and verapamil on coronary blood flow. J Invasive Cardiol 2000; 12: 80-5.
22. Gibson CM, Cannon CP, Murphy SA, et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 2000; 101: 125-30.
23. Lepper W, Sieswerda GT, Vanoverschelde JL, et al. Predictive value of markers of myocardial reperfusion in acute myocardial infarction for follow-up left ventricular function. Am J Cardiol 2001; 88: 1358-63.
24. Angeja BG, Gunda M, Murphy SA, et al. TIMI myocardial perfusion grade and ST segment resolution: association with infarct size as assessed by single photon emission computed tomography imaging. Circulation 2002; 105:282-5.
25. Gibson CM, Cannon CP, Murphy SA, et al. Relationship of the TIMI myocardial grades, flow grades, frame count, and percutaneous coronary intervention to long term outcomes after thrombolytic administration in acute myocardial infarction. Circulation 2002; 105: 1909-13.
26. Stone GW, Peterson MA, Lansky AJ, Dangas G, Mehran R, Leon MB. Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction. J Am Coll Cardiol 2002; 39: 591-7.
27. Gibson CM, Murphy SA, Rizzo MJ, et al. Relationship between TIMI frame count and clinical outcome after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) Study Group. Circulation 1999; 99: 1945-50.
28. Hamada S, Nishiue T, Nakamura S, et al. TIMI frame count immediately after primary coronary angioplasty as a predictor of functional recovery in patients with TIMI 3 reperfused acute myocardial infarction. J Am Coll Cardiol 2001; 38: 666-71.
29. Stone GW, Webb J, Cox DA, et al. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. JAMA 2005; 293: 1063-72.
30. Kunichika H, Ben-Yehuda O, Lafitte S, Kunichika N, Peters B, DeMaria AN. Effects of glycoprotein IIb/IIIa inhibition on microvascular flow after coronary reperfusion. A quantitative myocardial contrast echocardiography study. J Am Coll Cardiol 2004; 43: 276-83.